Detection and quantification of residual disease in chronic myelogenous leukemia
A Hochhaus, A Weisser, P La Rosee, M Emig… - Leukemia, 2000 - nature.com
The degree of tumor load reduction after therapy is an important prognostic factor for
patients with CML. Conventional metaphase analysis has been considered to be the 'gold …
patients with CML. Conventional metaphase analysis has been considered to be the 'gold …
Molecular monitoring of residual disease in chronic myelogenous leukemia patients after therapy
R Haas, R Kronenwett, G Sczakiel, A Hochhaus… - … in Hematopoietic Stem …, 1998 - Springer
The degree of tumor load reduction after therapy, which is determined by the degrees of
cytoreduction and cytogenetic response, is an important prognostic factor for patients with …
cytoreduction and cytogenetic response, is an important prognostic factor for patients with …
Minimal residual disease in chronic myeloid leukaemia.
NC Cross - Hematology and cell therapy, 1998 - europepmc.org
The principle aim of residual disease analysis in patients with chronic myeloid leukaemia
(CML) is to gauge patient response to treatment and, in patients after allogeneic BMT, to …
(CML) is to gauge patient response to treatment and, in patients after allogeneic BMT, to …
Clinical implications of qualitative and quantitative polymerase chain reaction analysis in the monitoring of patients with chronic myelogenous leukemia. The …
T Lion - Bone marrow transplantation, 1994 - europepmc.org
Recent progress in the development of diagnostic techniques has greatly facilitated the
monitoring of minimal residual disease (MRD) in patients with hematologic neoplasia. The …
monitoring of minimal residual disease (MRD) in patients with hematologic neoplasia. The …
Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real‐time quantitative RT‐PCR
Menskin, V De Locht, Schattenberg… - British journal of …, 1998 - Wiley Online Library
We used a recently developed system for real‐time quantitative polymerase chain reaction
(PCR) to determine residual disease in patients with chronic myeloid leukaemia. The …
(PCR) to determine residual disease in patients with chronic myeloid leukaemia. The …
Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a 'real time'quantitative RT-PCR assay
C Preudhomme, F Revillion, A Merlat, L Hornez… - Leukemia, 1999 - nature.com
Quantitative competitive RT-PCR techniques have been developed to detect BCR-ABL
fusion transcripts in CML but they are hardly reproducible. In this work, we have developed …
fusion transcripts in CML but they are hardly reproducible. In this work, we have developed …
[引用][C] Monitoring of residual disease in chronic myelogenous leukemia: Methodological approaches and clinical aspects.
T Lion - Leukemia, 1996 - europepmc.org
Monitoring of residual disease in chronic myelogenous leukemia: methodological approaches
and clinical aspects. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …
and clinical aspects. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …
Monitoring chronic myeloid leukaemia therapy by real‐time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics
We have developed a rapid real‐time quantitative PCR method for measuring BCR‐ABL
mRNA levels in peripheral blood in chronic myeloid leukaemia (CML). The technique was …
mRNA levels in peripheral blood in chronic myeloid leukaemia (CML). The technique was …
Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia
M Amabile, B Giannini, N Testoni, V Montefusco… - …, 2001 - haematologica.org
BACKGROUND AND OBJECTIVES: The most common translocation in chronic myeloid
leukemia (CML) t (9; 22)(q34; q22) produces the BCR/ABL fusion gene. We set up and …
leukemia (CML) t (9; 22)(q34; q22) produces the BCR/ABL fusion gene. We set up and …
Diagnosis and monitoring of chronic myeloid leukemia by qualitative and quantitative RT-PCR
S Branford, T Hughes - Myeloid Leukemia: Methods and Protocols, 2006 - Springer
Real-time quantitative reverse-transcription polymerase chain reaction (RQ-PCR) methods
for the quantitation of BCR-ABL mRNA in the blood of patients with chronic myeloid …
for the quantitation of BCR-ABL mRNA in the blood of patients with chronic myeloid …